Seattle biotech Kineta teams up with Genentech to create chronic pain medicine – Seattle Times

Zennie Abraham / Zennie62
Seattle biotech Kineta teams up with Genentech to create chronic pain medicine
Seattle Times
Seattle biotech Kineta will partner with big biotech company Genentech to make and sell a drug used to treat chronic pain, in a deal that could be worth more than $359 million for the Seattle company. Kineta announced Monday it made a deal with San

…read more

Source:: Seattle News By Google News

Keywords

News: Seattle biotech Kineta teams up with Genentech to create chronic pain medicine – Seattle Times - Seattle biotech Kineta teams up with Genentech to create chronic pain medicineSeattle TimesSeattle biotech Kineta will partner with big biotech...

Read the other blogs in the Zennie62Media network:

- OaklandNewsNow.com - OaklandNewsOnline.com

About the Author

Zennie Abraham
Zennie Abraham | Zennie Abraham or "Zennie62" is the founder of Zennie62Media which consists of zennie62blog.com and a multimedia blog news aggregator and video network, and 78-blog network, with social media and content development services and consulting. Zennie is a pioneer video blogger, YouTube Partner, social media practitioner, game developer, and pundit. Note: news aggregator content does not reflect the personal views of Mr. Abraham.

Be the first to comment on "Seattle biotech Kineta teams up with Genentech to create chronic pain medicine – Seattle Times"

Leave a comment